Compositions for mucosal and oral administration comprising hcg fragments

a technology of mucosal and oral administration, applied in the field of biotechnology, can solve the problems of life-threatening systemic disease, toxic when secreted into the circulation, and a host's deleterious
US20100004172A1Inactive Publication Date: 2010-01-07BIOTEMPT
43 Cites 34 Cited by

Patent Information

Authority / Receiving Office
US · United States
Patent Type
Applications(United States)
Current Assignee / Owner
BIOTEMPT
Publication Date
2010-01-07
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
Patent Text Reader

Abstract

The invention relates to the field of immunology, more specifically to the field of immune-mediated disorders such as allergies, auto-immune disease, transplantation-related disease and other inflammatory diseases. The invention in particular relates to the systemic treatment of inflammatory disease by oral or mucosal administration of a pharmaceutical composition with a gene-regulatory peptide. The invention provides a pharmaceutical composition in a form for mucosal application for the treatment of a subject suffering from disease, the pharmaceutical composition comprising a pharmacologically effective amount of a gene-regulatory peptide or a functional analogue thereof together with a pharmaceutically acceptable diluent.
Need to check novelty before this filing date? Find Prior Art

Description

CROSS-REFERENCE TO RELATED APPLICATIONS

[0001] This application is a divisional of co-pending U.S. patent application Ser. No. 11 / 243,438, filed Oct. 4, 2005, U.S. Pat. No. 7,517,529 (Apr. 14, 2009), which is a continuation of PCT International Patent Appl'n No. PCT / EP2004 / 003747, filed on Apr. 8, 2004, designating the United States of America, and published, in English, as PCT International Publication No. WO 2004 / 093897 on Nov. 4, 2004, which International Application itself claims priority to EP 03076028.4, filed Apr. 8, 2003 with the European Patent Office (EPO), EP 03076029.2, filed Apr. 8, 2003 with the EPO, of EP 03076027.6, filed Apr. 8, 2003, with the EPO, of EP 03076026.8, filed Apr. 8, 2003 with the EPO, of EP 03076022.7 filed Apr. 8, 2003 with the EPO, of U.S. Ser. No. 10 / 409,671, filed Apr. 8, 2003, of EP 03076021.9, filed Apr. 8, 2003 with the EPO, of EP 03076025.0, filed Apr. 8, 2003 with the EPO, of EP 03076024.3, filed Apr. 8, 2003 with the EPO, of EP 03076030.0, file...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More